Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.80
21.02.24
€46.24
21.02.25
12.85%
24.05.24

HC Wainwright 
21.02.24 50%
buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€7.90
20.02.24
€12.95
20.02.25
-25.73%
24.05.24

Jefferies Financial Group Inc. 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€11.70
20.02.24
€20.35
20.02.25
-21.18%
24.05.24

Wells Fargo & Company 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€11.80
20.02.24
€17.55
20.02.25
-21.85%
24.05.24

The Goldman Sachs Group, Inc. 
20.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€137.40
20.02.24
€217.07
20.02.25
-0.84%
24.05.24

Royal Bank of Canada 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€11.80
20.02.24
€16.63
20.02.25
-21.85%
24.05.24

Piper Sandler 
20.02.24 50%
sell
Alkermes plc

Start price
Target price
Perf. (%)
€28.00
20.02.24
€23.09
20.02.25
-20.71%
24.05.24

UBS Group AG 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€10.58
20.02.24
€31.41
20.02.25
-12.84%
24.05.24

Chardan Capital 
20.02.24 50%
sell
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€41.07
17.02.24
-
17.02.25
-16.31%
24.05.24

StockNews.com 
17.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€136.40
16.02.24
€210.72
16.02.25
-0.11%
24.05.24

Citigroup Inc. 
16.02.24 50%
buy
Agios Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€24.80
16.02.24
€38.99
16.02.25
26.61%
20.05.24

Royal Bank of Canada 
16.02.24 50%
buy
Alkermes plc

Start price
Target price
Perf. (%)
€29.80
16.02.24
€36.20
16.02.25
-25.50%
24.05.24

Piper Sandler 
16.02.24 50%
buy
Ironwood Pharmaceuticals

Start price
Target price
Perf. (%)
€13.50
16.02.24
€19.49
16.02.25
-59.63%
24.05.24

Piper Sandler 
16.02.24 50%
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€40.47
16.02.24
€47.44
16.02.25
-
29.01.24

Morgan Stanley 
16.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€139.00
16.02.24
€209.30
16.02.25
-1.98%
24.05.24

Chardan Capital 
16.02.24 50%
buy
Repligen Corp.

Start price
Target price
Perf. (%)
€191.20
15.02.24
€204.23
15.02.25
-23.80%
24.05.24

KeyCorp 
15.02.24 50%
buy
Charles River Labs Intl

Start price
Target price
Perf. (%)
€227.80
15.02.24
€246.00
15.02.25
-12.12%
24.05.24

Evercore ISI 
15.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€137.00
15.02.24
€185.66
15.02.25
-0.55%
24.05.24

Needham & Company LLC 
15.02.24 50%
buy
Charles River Labs Intl

Start price
Target price
Perf. (%)
€227.80
15.02.24
€269.47
15.02.25
-12.12%
24.05.24

UBS Group AG 
15.02.24 50%
buy
Charles River Labs Intl

Start price
Target price
Perf. (%)
€227.80
15.02.24
€248.57
15.02.25
-12.12%
24.05.24

Robert W. Baird 
15.02.24 50%
buy
Charles River Labs Intl

Start price
Target price
Perf. (%)
€227.80
15.02.24
€259.70
15.02.25
-12.12%
24.05.24

JPMorgan Chase & Co. 
15.02.24 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€44.60
15.02.24
€105.84
15.02.25
-16.14%
24.05.24

Cantor Fitzgerald 
15.02.24 50%
sell
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€53.84
15.02.24
-
15.02.25
-
23.01.24

StockNews.com 
15.02.24 50%
buy
Medpace Holdings Inc

Start price
Target price
Perf. (%)
€369.50
15.02.24
€419.64
15.02.25
-2.52%
24.05.24

UBS Group AG 
15.02.24 50%
sell
Evotec SE

Start price
Target price
Perf. (%)
€13.43
15.02.24
-
15.02.25
-33.36%
24.05.24

DirectorDealer 
15.02.24 50%